CNO FINANCIAL GROUP INC (CNO) Stock Fundamental Analysis
NYSE:CNO - New York Stock Exchange, Inc. - US12621E1038 - Common Stock - Currency: USD
CNO gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 143 industry peers in the Insurance industry. CNO has a medium profitability rating, but doesn't score so well on its financial health evaluation. CNO is not valued too expensively and it also shows a decent growth rate.
1. Profitability
1.1 Basic Checks
In the past year CNO was profitable.
CNO had a positive operating cash flow in the past year.
CNO had positive earnings in each of the past 5 years.
Each year in the past 5 years CNO had a positive operating cash flow.
1.2 Ratios
The Return On Assets of CNO (0.82%) is worse than 60.14% of its industry peers.
With a decent Return On Equity value of 12.07%, CNO is doing good in the industry, outperforming 61.54% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.82% | ||
| ROE | 12.07% | ||
| ROIC | N/A |
ROA(3y)1.25%
ROA(5y)1.24%
ROE(3y)21.43%
ROE(5y)16.13%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
CNO has a Profit Margin (6.99%) which is comparable to the rest of the industry.
CNO's Profit Margin has declined in the last couple of years.
The Operating Margin of CNO (15.63%) is better than 71.33% of its industry peers.
In the last couple of years the Operating Margin of CNO has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 15.63% | ||
| PM (TTM) | 6.99% | ||
| GM | N/A |
OM growth 3Y-3.08%
OM growth 5Y9.46%
PM growth 3Y-13.73%
PM growth 5Y-2.56%
GM growth 3YN/A
GM growth 5YN/A
2. Health
2.1 Basic Checks
CNO has less shares outstanding than it did 1 year ago.
The number of shares outstanding for CNO has been reduced compared to 5 years ago.
CNO has a worse debt/assets ratio than last year.
2.2 Solvency
The Debt to FCF ratio of CNO is 6.57, which is on the high side as it means it would take CNO, 6.57 years of fcf income to pay off all of its debts.
CNO's Debt to FCF ratio of 6.57 is on the low side compared to the rest of the industry. CNO is outperformed by 68.53% of its industry peers.
CNO has a Debt/Equity ratio of 1.74. This is a high value indicating a heavy dependency on external financing.
Looking at the Debt to Equity ratio, with a value of 1.74, CNO is doing worse than 90.91% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.74 | ||
| Debt/FCF | 6.57 | ||
| Altman-Z | N/A |
ROIC/WACCN/A
WACCN/A
2.3 Liquidity
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | N/A | ||
| Quick Ratio | N/A |
3. Growth
3.1 Past
CNO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 36.54%, which is quite impressive.
CNO shows quite a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 16.49% yearly.
CNO shows a small growth in Revenue. In the last year, the Revenue has grown by 0.10%.
Measured over the past years, CNO shows a small growth in Revenue. The Revenue has been growing by 2.35% on average per year.
EPS 1Y (TTM)36.54%
EPS 3Y12.53%
EPS 5Y16.49%
EPS Q2Q%51.92%
Revenue 1Y (TTM)0.1%
Revenue growth 3Y3.34%
Revenue growth 5Y2.35%
Sales Q2Q%-13.18%
3.2 Future
CNO is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 6.59% yearly.
Based on estimates for the next years, CNO will show a small growth in Revenue. The Revenue will grow by 3.66% on average per year.
EPS Next Y-3.83%
EPS Next 2Y3.89%
EPS Next 3Y6.26%
EPS Next 5Y6.59%
Revenue Next Year3.51%
Revenue Next 2Y3.28%
Revenue Next 3Y3.22%
Revenue Next 5Y3.66%
3.3 Evolution
The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 8.66, the valuation of CNO can be described as very reasonable.
Based on the Price/Earnings ratio, CNO is valued a bit cheaper than the industry average as 72.73% of the companies are valued more expensively.
CNO's Price/Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 26.31.
With a Price/Forward Earnings ratio of 8.56, the valuation of CNO can be described as very reasonable.
Compared to the rest of the industry, the Price/Forward Earnings ratio of CNO indicates a somewhat cheap valuation: CNO is cheaper than 62.94% of the companies listed in the same industry.
CNO is valuated cheaply when we compare the Price/Forward Earnings ratio to 22.13, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.66 | ||
| Fwd PE | 8.56 |
4.2 Price Multiples
67.83% of the companies in the same industry are more expensive than CNO, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 5.46 | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)0.52
EPS Next 2Y3.89%
EPS Next 3Y6.26%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 1.81%, CNO has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 3.31, CNO has a dividend in line with its industry peers.
CNO's Dividend Yield is slightly below the S&P500 average, which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.81% |
5.2 History
The dividend of CNO is nicely growing with an annual growth rate of 8.19%!
CNO has been paying a dividend for at least 10 years, so it has a reliable track record.
CNO has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)8.19%
Div Incr Years12
Div Non Decr Years12
5.3 Sustainability
22.04% of the earnings are spent on dividend by CNO. This is a low number and sustainable payout ratio.
The dividend of CNO is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP22.04%
EPS Next 2Y3.89%
EPS Next 3Y6.26%
36.88
-0.78 (-2.07%)
Chartmill FA Rating
GICS SectorFinancials
GICS IndustryGroupInsurance
GICS IndustryInsurance
Earnings (Last)
Earnings (Next)
Inst Owners97.39%
Inst Owner Change-0.17%
Ins Owners2.28%
Ins Owner Change0.95%
Market Cap3.66B
Analysts50.77
Price Target43.66 (18.38%)
Short Float %2.24%
Short Ratio2.73
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 1.81% |
Yearly Dividend0.64
Dividend Growth(5Y)8.19%
DP22.04%
Div Incr Years12
Div Non Decr Years12
Ex-Date
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)10.63%
Min EPS beat(2)-0.86%
Max EPS beat(2)22.13%
EPS beat(4)3
Avg EPS beat(4)25.43%
Min EPS beat(4)-0.86%
Max EPS beat(4)47.04%
EPS beat(8)5
Avg EPS beat(8)14.68%
EPS beat(12)7
Avg EPS beat(12)14.67%
EPS beat(16)10
Avg EPS beat(16)14.19%
Revenue beat(2)2
Avg Revenue beat(2)6.93%
Min Revenue beat(2)1.91%
Max Revenue beat(2)11.94%
Revenue beat(4)4
Avg Revenue beat(4)12.03%
Min Revenue beat(4)1.91%
Max Revenue beat(4)19.67%
Revenue beat(8)8
Avg Revenue beat(8)13.53%
Revenue beat(12)11
Avg Revenue beat(12)9.96%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.47%
PT rev (3m)-1.61%
EPS NQ rev (1m)-0.68%
EPS NQ rev (3m)-5.23%
EPS NY rev (1m)0%
EPS NY rev (3m)-0.41%
Revenue NQ rev (1m)-0.15%
Revenue NQ rev (3m)-0.44%
Revenue NY rev (1m)-0.25%
Revenue NY rev (3m)-0.35%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 8.66 | ||
| Fwd PE | 8.56 | ||
| P/S | 0.84 | ||
| P/FCF | 5.46 | ||
| P/OCF | 5.46 | ||
| P/B | 1.44 | ||
| P/tB | 1.44 | ||
| EV/EBITDA | N/A |
EPS(TTM)4.26
EY11.55%
EPS(NY)4.31
Fwd EY11.68%
FCF(TTM)6.76
FCFY18.32%
OCF(TTM)6.76
OCFY18.32%
SpS44.04
BVpS25.52
TBVpS25.52
PEG (NY)N/A
PEG (5Y)0.52
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.82% | ||
| ROE | 12.07% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | 15.63% | ||
| PM (TTM) | 6.99% | ||
| GM | N/A | ||
| FCFM | 15.34% |
ROA(3y)1.25%
ROA(5y)1.24%
ROE(3y)21.43%
ROE(5y)16.13%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)2.15%
ROCE(5y)1.99%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-3.08%
OM growth 5Y9.46%
PM growth 3Y-13.73%
PM growth 5Y-2.56%
GM growth 3YN/A
GM growth 5YN/A
F-Score4
Asset Turnover0.12
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.74 | ||
| Debt/FCF | 6.57 | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | N/A | ||
| Cap/Sales | N/A | ||
| Interest Coverage | 250 | ||
| Cash Conversion | N/A | ||
| Profit Quality | 219.32% | ||
| Current Ratio | N/A | ||
| Quick Ratio | N/A | ||
| Altman-Z | N/A |
F-Score4
WACCN/A
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)148.25%
Profit Quality(5y)158.67%
High Growth Momentum
Growth
EPS 1Y (TTM)36.54%
EPS 3Y12.53%
EPS 5Y16.49%
EPS Q2Q%51.92%
EPS Next Y-3.83%
EPS Next 2Y3.89%
EPS Next 3Y6.26%
EPS Next 5Y6.59%
Revenue 1Y (TTM)0.1%
Revenue growth 3Y3.34%
Revenue growth 5Y2.35%
Sales Q2Q%-13.18%
Revenue Next Year3.51%
Revenue Next 2Y3.28%
Revenue Next 3Y3.22%
Revenue Next 5Y3.66%
EBIT growth 1Y-10.56%
EBIT growth 3Y0.16%
EBIT growth 5Y12.04%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y28.59%
FCF growth 3Y1.61%
FCF growth 5Y-2.06%
OCF growth 1Y28.59%
OCF growth 3Y1.61%
OCF growth 5Y-2.06%